A surgical ICU has implemented multiple interventions over 18 months: chlorhexidine bathing, antibiotic stewardship, contact precautions for MRSA, and environmental cleaning protocols. Despite these efforts, MRSA surgical site infection rates remain unchanged at 8 per 1000 surgical procedures. Universal MRSA screening shows 15% of admitted patients are colonized. Evaluate the most effective evidence-based strategy to reduce MRSA SSI rates further.
Q2
A 70-year-old man with prosthetic aortic valve develops fever and bacteremia 3 weeks after valve replacement. Blood cultures grow Enterococcus faecium resistant to ampicillin and vancomycin (VRE). Susceptibilities show sensitivity to linezolid and daptomycin. TEE shows a small vegetation on the prosthetic valve. Creatinine is 1.8 mg/dL (baseline 1.0). Evaluate the optimal treatment strategy considering the infection location and drug characteristics.
Q3
A hospital implements a bundle to reduce catheter-associated urinary tract infections (CAUTI): daily review of catheter necessity, aseptic insertion technique, and proper maintenance. After 6 months, CAUTI rates decrease by 40% but then plateau. Compliance audits show 95% adherence to the bundle. The infection control team must evaluate the next intervention to achieve further reduction.
Q4
A 58-year-old woman with cirrhosis undergoes liver transplantation. On postoperative day 14, she develops fever, confusion, and abdominal pain. CT shows fluid collection near the biliary anastomosis. Aspiration yields purulent material. Culture grows Candida glabrata. She is on prophylactic fluconazole. Analyze the management failure and appropriate intervention.
Q5
An ICU experiences a cluster of 5 ventilator-associated pneumonia cases over 2 weeks. All isolates are Pseudomonas aeruginosa with identical antibiotic resistance patterns (resistant to cefepime, piperacillin-tazobactam, but susceptible to colistin). The affected patients are in different rooms. Environmental cultures from ventilator circuits are negative. Analyze the most likely source and transmission mechanism.
Q6
A 62-year-old man in the ICU for septic shock has been on broad-spectrum antibiotics (vancomycin, meropenem, micafungin) for 10 days. Initial blood cultures grew MRSA, now cleared. He develops new fever (38.8°C) and hypotension. Repeat blood cultures at 48 hours show no growth. He has a central line, Foley catheter, and endotracheal tube. Analysis of the clinical situation suggests which most likely explanation for persistent fever?
Q7
A 45-year-old diabetic woman develops fever and altered mental status 4 days after kidney transplantation. She is on tacrolimus and prednisone. Temperature is 39.4°C, BP 90/60 mmHg. Urinalysis shows WBCs and bacteria. Blood and urine cultures grow Escherichia coli resistant to ceftriaxone but susceptible to carbapenems, aminoglycosides, and trimethoprim-sulfamethoxazole. She has normal renal function. Apply the optimal long-term antibiotic choice.
Q8
A 72-year-old man undergoes colon resection for adenocarcinoma. On postoperative day 5, he develops watery diarrhea (8 episodes/day), abdominal cramping, and fever (38.5°C). He has been receiving cefoxitin prophylaxis extended postoperatively. WBC count is 18,000/μL. Stool studies are pending. Apply the most appropriate initial management.
Q9
A 55-year-old man with acute myeloid leukemia is hospitalized for chemotherapy. On day 7 of neutropenia (ANC 200/μL), he develops fever to 39.2°C and hypotension. Blood cultures from his central venous catheter grow gram-positive cocci in clusters. He has a history of anaphylaxis to penicillin with angioedema. Apply the most appropriate antibiotic therapy.
Q10
A 68-year-old woman undergoes elective hip replacement surgery. On postoperative day 3, she develops fever (38.9°C), productive cough, and shortness of breath. Chest X-ray shows a right lower lobe infiltrate. She has been on mechanical ventilation for 48 hours due to perioperative complications. Sputum Gram stain shows gram-negative rods. Apply the appropriate empiric antibiotic regimen.
Hospital-acquired infections US Medical PG Practice Questions and MCQs
Question 1: A surgical ICU has implemented multiple interventions over 18 months: chlorhexidine bathing, antibiotic stewardship, contact precautions for MRSA, and environmental cleaning protocols. Despite these efforts, MRSA surgical site infection rates remain unchanged at 8 per 1000 surgical procedures. Universal MRSA screening shows 15% of admitted patients are colonized. Evaluate the most effective evidence-based strategy to reduce MRSA SSI rates further.
A. Targeted decolonization only for MRSA-positive patients with mupirocin and chlorhexidine
B. Isolation of all surgical patients in private rooms until discharge
C. Routine screening and decolonization of all healthcare workers
D. Extended vancomycin prophylaxis for all surgical patients for 48 hours postoperatively
E. Universal MRSA decolonization for all surgical patients regardless of screening results (Correct Answer)
Explanation: ***Universal MRSA decolonization for all surgical patients regardless of screening results***
- **Universal decolonization** has been proven more effective than screening-based strategies in high-risk settings like the ICU, significantly reducing **MRSA surgical site infections** and bloodstream infections.
- This approach is superior because it addresses **undetected carriers**, eliminates delays associated with waiting for lab cultures, and is often more **cost-effective** and easier to implement.
*Targeted decolonization only for MRSA-positive patients with mupirocin and chlorhexidine*
- While logical, **targeted decolonization** is less effective than the universal approach because it misses patients who may be **falsely negative** or colonized at levels below detection thresholds.
- Evidence from recent large-scale trials shows that **targeted strategies** do not reduce MRSA infection rates as drastically as treating the entire cohort at risk.
*Isolation of all surgical patients in private rooms until discharge*
- This strategy is **logistically impractical** and extremely expensive, focusing on **containment** rather than the active reduction of the patient's own bacterial load (colonization).
- Research indicates that **contact precautions** and isolation alone are less effective than decolonization protocols in preventing **autoinoculation** during surgery.
*Routine screening and decolonization of all healthcare workers*
- Screening of **healthcare workers (HCWs)** is not recommended as a routine practice; it is typically reserved for **outbreak investigations** where an epidemiological link is suspected.
- Constant recolonization from patients and the environment makes **HCW decolonization** an unsustainable and transient solution for reducing overall SSI rates.
*Extended vancomycin prophylaxis for all surgical patients for 48 hours postoperatively*
- **Extended antibiotic prophylaxis** beyond 24 hours provides no additional protection against SSIs and significantly increases the risk of **C. difficile** and antibiotic resistance.
- Proper surgical prophylaxis involves **timely administration** before the incision, not prolonged courses which violate **antibiotic stewardship** principles.
Question 2: A 70-year-old man with prosthetic aortic valve develops fever and bacteremia 3 weeks after valve replacement. Blood cultures grow Enterococcus faecium resistant to ampicillin and vancomycin (VRE). Susceptibilities show sensitivity to linezolid and daptomycin. TEE shows a small vegetation on the prosthetic valve. Creatinine is 1.8 mg/dL (baseline 1.0). Evaluate the optimal treatment strategy considering the infection location and drug characteristics.
A. Combination daptomycin and linezolid (Correct Answer)
B. Linezolid plus gentamicin for synergy
C. Daptomycin plus ampicillin despite resistance
D. Daptomycin monotherapy with high dose (10-12 mg/kg)
E. Linezolid monotherapy for 6 weeks
Explanation: ***Combination daptomycin and linezolid***
- For **VRE prosthetic valve endocarditis (PVE)**, monotherapy often fails due to high bacterial inoculum and **biofilm formation**, necessitating synergistic combinations.
- **Daptomycin** provides bactericidal activity, while **linezolid** enhances biofilm penetration; this combination is a salvage strategy to prevent the emergence of **daptomycin resistance** during prolonged therapy.
*Linezolid plus gentamicin for synergy*
- **Gentamicin** synergy is typically reserved for **ampicillin-susceptible** enterococci and requires a cell-wall active agent to facilitate entry, which linezolid (protein synthesis inhibitor) does not provide.
- The patient has an elevated **creatinine (1.8 mg/dL)**, making the use of **nephrotoxic aminoglycosides** like gentamicin highly risky and suboptimal.
*Daptomycin plus ampicillin despite resistance*
- While **ampicillin** can sometimes enhance daptomycin binding by reducing the net negative surface charge of the bacteria, it is generally less effective when high-level **ampicillin resistance** is already confirmed in *E. faecium*.
- This strategy is typically considered when other secondary agents are unavailable or contraindicated, but it is not superior to linezolid-based combinations in VRE endocarditis.
*Daptomycin monotherapy with high dose (10-12 mg/kg)*
- High-dose **daptomycin (10-12 mg/kg)** is recommended for endocarditis, but monotherapy for **prosthetic valve** infections carries a high risk of treatment failure.
- *Enterococcus faecium* can rapidly develop **resistance** (via the LiaFSR system) during daptomycin monotherapy, making a second agent necessary for such a high-burden infection.
*Linezolid monotherapy for 6 weeks*
- **Linezolid** is primarily **bacteriostatic** against enterococci, which is generally insufficient for the definitive treatment of **infective endocarditis** where bactericidal activity is required.
- Long-term use (over 2 weeks) carries significant risks of **bone marrow suppression** (thrombocytopenia) and **mitochondrial toxicity**, making it unsafe as a sole agent for a 6-week course.
Question 3: A hospital implements a bundle to reduce catheter-associated urinary tract infections (CAUTI): daily review of catheter necessity, aseptic insertion technique, and proper maintenance. After 6 months, CAUTI rates decrease by 40% but then plateau. Compliance audits show 95% adherence to the bundle. The infection control team must evaluate the next intervention to achieve further reduction.
A. Focus on reducing overall catheter utilization and early removal (Correct Answer)
B. Increase frequency of catheter changes to every 72 hours
C. Switch to suprapubic catheters for long-term needs
D. Add prophylactic antibiotics for catheterized patients
E. Implement antimicrobial-coated catheters for all patients
Explanation: ***Focus on reducing overall catheter utilization and early removal***
- Since **compliance** with the bundle is already high at **95%**, the most influential risk factor for infection remains the **duration of catheterization**.
- Implementing **nurse-driven protocols** for early removal and utilizing **bladder scanners** to avoid insertion are the most effective strategies to further reduce **CAUTI** rates.
*Increase frequency of catheter changes to every 72 hours*
- Routine **scheduled catheter changes** are not recommended as they increase the risk of introducing **uropathogens** into the bladder during the procedure.
- Catheters should only be changed if there is a clinical indication, such as **obstruction**, **leakage**, or established **infection**.
*Switch to suprapubic catheters for long-term needs*
- **Suprapubic catheters** are invasive surgical procedures that may carry risks of **bowel injury** and are not indicated for general hospital-wide infection reduction.
- While they may reduce some urethral complications, they do not fundamentally eliminate the risk of **biofilm formation** and subsequent bacteriuria.
*Add prophylactic antibiotics for catheterized patients*
- Routine use of **prophylactic antibiotics** is strongly discouraged because it fosters the development of **multi-drug resistant organisms (MDROs)**.
- Evidence shows it does not prevent long-term **CAUTI** and may lead to complications like **Clostridioides difficile** infection.
*Implement antimicrobial-coated catheters for all patients*
- There is **limited clinical evidence** that antimicrobial-coated catheters provide a significant, cost-effective reduction in **symptomatic CAUTIs** compared to standard catheters.
- These are generally reserved for high-risk patients or specific units where other **prevention bundles** have consistently failed, rather than universal implementation.
Question 4: A 58-year-old woman with cirrhosis undergoes liver transplantation. On postoperative day 14, she develops fever, confusion, and abdominal pain. CT shows fluid collection near the biliary anastomosis. Aspiration yields purulent material. Culture grows Candida glabrata. She is on prophylactic fluconazole. Analyze the management failure and appropriate intervention.
A. Switch to micafungin or an echinocandin and percutaneous drainage (Correct Answer)
B. Add amphotericin B to fluconazole regimen
C. Surgical exploration and fluconazole continuation
D. Switch to voriconazole and percutaneous drainage
E. Increase fluconazole dose and continue current management
Explanation: ***Switch to micafungin or an echinocandin and percutaneous drainage***
- **Candida glabrata** frequently exhibits **intrinsic resistance** or reduced susceptibility to **fluconazole**, making echinocandins the preferred first-line therapy.
- **Percutaneous drainage** is critical for **source control** of an infected fluid collection (abscess) near the biliary anastomosis.
*Add amphotericin B to fluconazole regimen*
- Combining antifungals is not standard for this scenario and **Amphotericin B** carries a high risk of **nephrotoxicity**, which is undesirable in a post-transplant patient.
- Fluconazole would remain ineffective against **C. glabrata**, and the intra-abdominal collection still requires **mechanical drainage**.
*Surgical exploration and fluconazole continuation*
- **Surgical exploration** is an invasive last resort; **percutaneous drainage** is the standard initial approach for localized fluid collections.
- Continuing **fluconazole** is inappropriate as the infection emerged while the patient was already on fluconazole prophylaxis, indicating **treatment failure**.
*Switch to voriconazole and percutaneous drainage*
- While drainage is correct, **voriconazole** is not the primary choice because **cross-resistance** between fluconazole and other azoles is common in **C. glabrata**.
- **Echinocandins** provide much more reliable bactericidal activity against non-albicans Candida species in the inpatient setting.
*Increase fluconazole dose and continue current management*
- Increasing the dose is unlikely to overcome the **resistance mechanism** of **C. glabrata** once an invasive infection has established.
- This approach ignores the necessity of **source control**, as antifungal therapy alone cannot penetrate and sterilize a large **purulent collection**.
Question 5: An ICU experiences a cluster of 5 ventilator-associated pneumonia cases over 2 weeks. All isolates are Pseudomonas aeruginosa with identical antibiotic resistance patterns (resistant to cefepime, piperacillin-tazobactam, but susceptible to colistin). The affected patients are in different rooms. Environmental cultures from ventilator circuits are negative. Analyze the most likely source and transmission mechanism.
A. Contaminated batch of respiratory therapy equipment
B. Patient-to-patient transmission via contaminated stethoscopes
C. Endogenous activation of colonizing flora in multiple patients
D. Healthcare worker hand transmission with inadequate hygiene
E. Contaminated hospital water supply with aerosol transmission (Correct Answer)
Explanation: ***Contaminated hospital water supply with aerosol transmission***
- **Pseudomonas aeruginosa** is a ubiquitous environmental organism that frequently colonizes **hospital water systems**, including sinks, taps, and drains, forming resilient **biofilms**.
- A cluster of cases with **identical antibiotic resistance patterns** spreading across different rooms, despite negative ventilator circuit cultures, strongly points to a shared **environmental reservoir** like the water supply.
*Contaminated batch of respiratory therapy equipment*
- While possible, the negative cultures from **ventilator circuits** specifically rule out the most common equipment-related source for **VAP** clusters.
- Modern sterilization and **single-use disposables** have significantly reduced outbreaks stemming from manufacturers' equipment batches.
*Patient-to-patient transmission via contaminated stethoscopes*
- While **fomites** like stethoscopes can carry pathogens, they are unlikely to be the primary driver for a specific cluster of identical **multidrug-resistant** Pseudomonas strains across multiple rooms.
- Stethoscopes usually carry **skin flora** (like Staphylococcus) rather than the heavy aquatic-based load required to initiate a **pneumonia** outbreak.
*Endogenous activation of colonizing flora in multiple patients*
- Endogenous activation involves the patient's own unique flora; it would be highly improbable for five different patients to spontaneously activate strains with **identical resistance profiles** (cefepime/piperacillin-resistant).
- This scenario occurs sporadically rather than in a **temporal cluster**, which instead suggests an exogenous **point source**.
*Healthcare worker hand transmission with inadequate hygiene*
- **Hand hygiene** failures typically lead to the spread of various pathogens; however, the negative environmental cultures on the machines diminish the likelihood of surface-to-hand-to-patient spread in this specific case.
- While hand transmission is common, the **aquatic nature** of Pseudomonas makes a water source more statistically likely for a cluster involving identical environmental strains.
Question 6: A 62-year-old man in the ICU for septic shock has been on broad-spectrum antibiotics (vancomycin, meropenem, micafungin) for 10 days. Initial blood cultures grew MRSA, now cleared. He develops new fever (38.8°C) and hypotension. Repeat blood cultures at 48 hours show no growth. He has a central line, Foley catheter, and endotracheal tube. Analysis of the clinical situation suggests which most likely explanation for persistent fever?
A. Drug fever from vancomycin requiring medication change (Correct Answer)
B. Unrecognized catheter-related infection with biofilm formation
C. Immune reconstitution inflammatory syndrome
D. Resistant fungal infection not covered by micafungin
E. Inadequate MRSA source control requiring surgical intervention
Explanation: ***Drug fever from vancomycin requiring medication change***
- **Drug fever** is a diagnosis of exclusion in the ICU, typically occurring after **7–14 days** of therapy with common agents like **vancomycin** or beta-lactams.
- The clinical scenario of **persistent fever** despite cleared initial cultures and **negative 48-hour repeat cultures** strongly points toward a medication-induced rather than an infectious etiology.
*Unrecognized catheter-related infection with biofilm formation*
- **Biofilm formation** can shield bacteria from antibiotics, but repeat **blood cultures** would typically remain positive/recurrent if a catheter infection was the source.
- The fact that **initial blood cultures were cleared** and new ones are negative makes a primary bacterial catheter infection less likely than drug-related causes.
*Immune reconstitution inflammatory syndrome*
- **IRIS** occurs in profoundly immunocompromised patients, such as those with **HIV/AIDS**, when starting antiretroviral therapy and the immune system reacts to a latent pathogen.
- This patient is in **septic shock** but there is no evidence of underlying advanced HIV infection to justify a diagnosis of IRIS.
*Resistant fungal infection not covered by micafungin*
- While **candidemia** or **invasive aspergillosis** are concerns in ICU patients, he is already receiving **micafungin**, which covers most common *Candida* and *Aspergillus* species.
- A fungal infection would likely remain clinically evident or eventually show up in **fungal-specific cultures** rather than manifesting as isolated fever with sterile blood cultures.
*Inadequate MRSA source control requiring surgical intervention*
- Inadequate source control usually leads to **persistent bacteremia** or localized signs such as **abscess formation** or leukocytosis.
- Since the initial **MRSA bacteremia has cleared**, a hidden surgical source of the original infection is an unlikely cause of a *new* febrile spike after 10 days of appropriate therapy.
Question 7: A 45-year-old diabetic woman develops fever and altered mental status 4 days after kidney transplantation. She is on tacrolimus and prednisone. Temperature is 39.4°C, BP 90/60 mmHg. Urinalysis shows WBCs and bacteria. Blood and urine cultures grow Escherichia coli resistant to ceftriaxone but susceptible to carbapenems, aminoglycosides, and trimethoprim-sulfamethoxazole. She has normal renal function. Apply the optimal long-term antibiotic choice.
A. Trimethoprim-sulfamethoxazole for 14 days
B. Ertapenem for 7 days followed by trimethoprim-sulfamethoxazole (Correct Answer)
C. Continuous meropenem until immunosuppression is reduced
D. Gentamicin for 14 days
E. Meropenem for 14 days
Explanation: ***Ertapenem for 7 days followed by trimethoprim-sulfamethoxazole***
- The organism is an **ESBL-producing E. coli** (indicated by ceftriaxone resistance and carbapenem susceptibility); initial treatment with a **carbapenem** like ertapenem is necessary for clinical stabilization in a septic patient.
- De-escalating to oral **trimethoprim-sulfamethoxazole** once the patient is stable and susceptibilities are confirmed is an essential **antimicrobial stewardship** practice to reduce carbapenem exposure.
*Trimethoprim-sulfamethoxazole for 14 days*
- Although the isolate is susceptible, starting with oral therapy alone is inappropriate for a **transplant recipient** presenting with **septic shock** and altered mental status.
- Initial **parenteral therapy** is required to ensure rapid therapeutic levels and clinical control in the setting of severe systemic infection.
*Continuous meropenem until immunosuppression is reduced*
- Meropenem is usually reserved for **ESBL infections** with potential **Pseudomonas** coverage; however, this isolate is an E. coli which makes the narrower-spectrum ertapenem a better choice.
- Immunosuppression is necessary to prevent **graft rejection**, and reducing it is not the primary management strategy for a bacterial UTI that can be treated with antibiotics.
*Gentamicin for 14 days*
- Aminoglycosides like gentamicin carry a high risk of **nephrotoxicity**, which is particularly concerning in a **kidney transplant** recipient.
- While the organism is susceptible, gentamicin is rarely used as monotherapy for systemic infections when safer, highly effective options like **carbapenems** are available.
*Meropenem for 14 days*
- A 14-day course of intravenous meropenem is unnecessary and may contribute to the development of **carbapenem-resistant Enterobacteriaceae (CRE)**.
- Transitioning to an oral agent (de-escalation) is preferred over prolonged IV carbapenem therapy once **clinical stability** is achieved.
Question 8: A 72-year-old man undergoes colon resection for adenocarcinoma. On postoperative day 5, he develops watery diarrhea (8 episodes/day), abdominal cramping, and fever (38.5°C). He has been receiving cefoxitin prophylaxis extended postoperatively. WBC count is 18,000/μL. Stool studies are pending. Apply the most appropriate initial management.
A. Add loperamide for symptom control
B. Start ciprofloxacin for suspected bacterial gastroenteritis
C. Initiate total parenteral nutrition
D. Discontinue cefoxitin and start oral vancomycin (Correct Answer)
E. Continue current antibiotics and add metronidazole
Explanation: ***Discontinue cefoxitin and start oral vancomycin***
- The patient presents with classic signs of **Clostridioides difficile infection (CDI)**—watery diarrhea, fever, and **leukocytosis**—following recent **antibiotic exposure** (cefoxitin).
- The primary management involves stopping the offending antibiotic and initiating **oral vancomycin** or fidaxomicin, which are now preferred over metronidazole for initial episodes.
*Add loperamide for symptom control*
- **Antiperistaltic agents** like loperamide are strictly contraindicated in suspected CDI because they decrease toxin clearance.
- Using these agents can lead to severe complications, including **toxic megacolon** and colonic perforation.
*Start ciprofloxacin for suspected bacterial gastroenteritis*
- Fluoroquinolones like **ciprofloxacin** are common triggers for CDI and will not treat the underlying C. difficile infection.
- Standard bacterial gastroenteritis is less likely than **nosocomial CDI** in a post-surgical patient already receiving prophylactic antibiotics.
*Initiate total parenteral nutrition*
- While the patient has diarrhea, there is no indication of **malabsorption** or bowel failure necessitating **TPN** at this stage.
- Management must focus on treating the **infectious etiology** and maintaining oral or IV hydration rather than parenteral nutrition.
*Continue current antibiotics and add metronidazole*
- The **inciting antibiotic** (cefoxitin) should be discontinued immediately to remove the selective pressure allowing C. difficile to flourish.
- **Metronidazole** is no longer the first-line recommendation for clinical CDI due to inferior efficacy compared to **oral vancomycin**.
Question 9: A 55-year-old man with acute myeloid leukemia is hospitalized for chemotherapy. On day 7 of neutropenia (ANC 200/μL), he develops fever to 39.2°C and hypotension. Blood cultures from his central venous catheter grow gram-positive cocci in clusters. He has a history of anaphylaxis to penicillin with angioedema. Apply the most appropriate antibiotic therapy.
A. Cefepime
B. Daptomycin (Correct Answer)
C. Imipenem
D. Ciprofloxacin
E. Linezolid
Explanation: ***Daptomycin***
- Daptomycin is a **bactericidal** agent effective against **Gram-positive cocci**, including MRSA and Coagulase-negative Staphylococci, and is ideal for **catheter-related bloodstream infections**.
- Since the patient has a history of **anaphylaxis to penicillin**, daptomycin is a safe choice as it has no cross-reactivity with **beta-lactam antibiotics**.
*Cefepime*
- This is a **fourth-generation cephalosporin** that provides coverage for Pseudomonas, but it is contraindicated here due to the patient's history of **anaphylaxis/angioedema** to penicillin.
- While it has some Gram-positive activity, it is not the preferred treatment for suspected **MRSA** or catheter-associated cluster-forming Gram-positive cocci in this high-risk patient.
*Imipenem*
- This carbapenem is usually reserved for **multidrug-resistant Gram-negative** infections in neutropenic fever and possesses significant Gram-positive activity.
- It is avoided in this scenario because patients with severe **type 1 hypersensitivity (anaphylaxis)** to penicillin carry a risk of cross-reactivity with **carbapenems**.
*Ciprofloxacin*
- This fluoroquinolone is primarily used for **Gram-negative coverage** and is often used for prophylaxis in neutropenic patients rather than primary treatment of Gram-positive bacteremia.
- It lacks sufficient reliable activity against **Staphylococci** (Gram-positive cocci in clusters) to be used as monotherapy for a catheter-related infection.
*Linezolid*
- While effective against resistant Gram-positive organisms, Linezolid is primarily **bacteriostatic** and is generally not preferred over bactericidal agents for **bacteremia** or endovascular infections.
- Prolonged use in neutropenic patients is discouraged due to potential **myelosuppression** (thrombocytopenia), which can worsen the patient's existing hematologic condition.
Question 10: A 68-year-old woman undergoes elective hip replacement surgery. On postoperative day 3, she develops fever (38.9°C), productive cough, and shortness of breath. Chest X-ray shows a right lower lobe infiltrate. She has been on mechanical ventilation for 48 hours due to perioperative complications. Sputum Gram stain shows gram-negative rods. Apply the appropriate empiric antibiotic regimen.
A. Ceftriaxone and azithromycin
B. Vancomycin alone
C. Piperacillin-tazobactam and vancomycin (Correct Answer)
D. Amoxicillin-clavulanate
E. Levofloxacin alone
Explanation: ***Piperacillin-tazobactam and vancomycin***
- This patient satisfies the criteria for **Ventilator-Associated Pneumonia (VAP)**, having developed a new pulmonary infiltrate more than **48 hours after endotracheal intubation**.
- Empiric therapy must cover multidrug-resistant pathogens including **Pseudomonas aeruginosa** (provided by piperacillin-tazobactam) and **Methicillin-resistant Staphylococcus aureus (MRSA)** (provided by vancomycin).
*Ceftriaxone and azithromycin*
- This regimen is the standard treatment for **Community-Acquired Pneumonia (CAP)** targeting Streptococcus pneumoniae and atypicals.
- It lacks sufficient coverage for **Pseudomonas aeruginosa** and **MRSA**, which are highly prevalent in hospital settings and VAP.
*Vancomycin alone*
- While vancomycin provides excellent coverage for **Gram-positive** bacteria like **MRSA**, it has no activity against **Gram-negative bacilli**.
- Since the sputum Gram stain specifically showed **gram-negative rods**, omitting a beta-lactam or aminoglycoside would lead to treatment failure.
*Amoxicillin-clavulanate*
- This oral or IV medication is typically used for mild infections or **aspiration pneumonia** occurring in a community setting.
- It is not considered broad-spectrum enough for **nosocomial infections** and does not cover **Pseudomonas** or **MRSA**.
*Levofloxacin alone*
- Fluoroquinolone monotherapy is generally insufficient for empiric VAP treatment in patients with high risk for **multidrug resistance**.
- There is a high risk of resistance if used alone, and it does not provide reliable coverage for **MRSA** in a hospital environment.
